Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

Abstract

loading...

About

This paper, published in 1950, received 1.7k indexed citations. Written by Rakesh K. Jain covering the research area of Molecular Biology, Cancer Research and Oncology. It is primarily cited by scholars working on Molecular Biology (882 citations), Cancer Research (602 citations) and Oncology (590 citations). Published in Nature Medicine.

Countries where authors are citing Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

Since Specialization
Citations

This map shows the geographic impact of Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy more than expected).

Fields of papers citing Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm0901-987.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026